A randomised clinical trial on the effectiveness of Emla and Rapydan for prevention of vena punction-induced pain in children.

A randomised clinical trial on the effectiveness of Emla and Rapydan for prevention of vena punction-induced pain in children. - Pain perception after vena punction.

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35993

Enrollment

200

Registered

2011-03-28

Start date

2011-03-31

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pijnbeleving Pain perception/ discomfort

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Age 3 - 18

Exclusion criteria

Exclusion criteria: Allergy for the contents of the plaster

Design outcomes

Primary

Measure	Time frame
Pain score on "pain face-scale".	—

Secondary

Measure	Time frame
Redness, Swelling, Access to the vein.	—

Countries

Netherlands

Outcome results